Go it alone or do a deal??, page-23

@Svall

Oh how your sentiment has changed since this your initial post below

I think Antisense has burned through more than 50m in funds since inception and doesn't have a single product to its name, a quick look at balance sheet would reveal that, and might be impacting how people see this company

Around 20 years ago the stock was closer to $1.50
10 years ago closer to 40c

This is a classic example of a zombie biotech - burning through funds continually with no improvement in share price or profits to speak of.
Question is, will it stay this way, or will the company's fortunes reverse?

Also why aren't any management holding significant amounts of stock? Doesn't inspire much confidence if you ask me.

Criticisms welcome

Svall
It would now appear you have your fill now and willing to get stuck into some of our longer term holders Akki in particular for his thoughts

and all of a sudden you have turned into a BIOTECH SPECIALIST that is actually working in the biotech field yet you found it pertinent to call ANP
( Quote)
a classic example of a zombie biotech LOL

Then follow up down the track with

Also I'd say going from nothing to good phase 2 results inside 2 years isn’t "plodding along slowly"

Taken from the FDA site

Today, the path from initial demonstration that a molecule may have therapeutic potential to the production of an approved drug involves pre-clinical testing, complex clinical trials in humans, and post-trial regulatory approval by the FDA. For drugs, this process can take 10 to 15 years and cost millions of dollars

This board have been going for 20yrs now and we are still years away from market ???

IF THATS NOT PLODDING I DONT KNOW WHAT IS

And you go on to say to a poster

Have you even stepped foot in a lab or biotech office in your life? Because it sure as hell doesn't sound like it

REALLY

It would appear that even you are more aware of the goings on in the FDA than our CEO in Mark Diamond

In my recent post i quoted as per below

The simple fact is we will not be allocated a voucher until commercialization and there is no guarantee we will be allocated one at that time

Svall to which you replied

Actually the voucher is guaranteed if ATL1102 gains approval just fyi

Well Svall FYI

Please take note

Mark Diamonds own words not mine FYI

“The designation doesn’t guarantee a voucher, you still need to meet the eligibility criteria,” Mr Diamond says. “But having the designation gives you confidence the FDA believes the disease you are treating meets their conditions.”

So it would appear that my statement was correct Svall

I wonder just how much research the people that give the likes of yourself TU actually do

If you are so knowledgeable Svall and you are in a smaller Biotech than ANP we have an AGM coming up in the next few weeks, maybe its time to step up

Please Svall throw your hat in the ring to be nominated as our new CEO you will get my vote

Because lets face it Svall with your experience i coudnt really see you performing much worse than the leader of this ZOMBIE BIOTECH that is just BURNING through FUNDS the way you say they are

Enjoy your Wk/end LT

they come and they go LOL

See how we go